These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5721243)

  • 21. [Analysis method of complex excipients for ointments and suppositories. II. Analysis of a complex mixture with glyceride base].
    Aiache JM; Aiache S; Febvre P
    Ann Pharm Fr; 1969; 27(9):575-80. PubMed ID: 5368593
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibility of the use of Soviet-made fatty bases for the preparation of suppositories with some hormones].
    Tentsova AI; Azhgikhin IS; Sergeev VV
    Farmatsiia; 1970; 19(4):17-21. PubMed ID: 5488012
    [No Abstract]   [Full Text] [Related]  

  • 23. [Method for the determination of the solubility of drugs in ointment and suppositories bases].
    Mayer A; Kata M
    Pharmazie; 1973 Mar; 28(3):214-5. PubMed ID: 4700929
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of surface-limiting reactions of colloid silicic acid on hard-fat-base suppositories containing active substances. 2. Liberation from solution- and suspension-suppositories].
    Liebi H; Haggag A; Rupprecht H
    Pharmazie; 1977 Jun; 32(6):354. PubMed ID: 197549
    [No Abstract]   [Full Text] [Related]  

  • 25. [Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories].
    Golovkin VA; Lukash EP; Fadeicheva AG; Groshovyĭ TA; Mokhort NA
    Farmatsiia; 1978; 27(4):16-9. PubMed ID: 689174
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro studies on rectal oxytetracycline resorption. Is the preparation of suppositories of tetracycline-antibiotics sensible?].
    Hüttenrauch R; Keil R
    Pharmazie; 1969 Mar; 24(3):159-61. PubMed ID: 5787493
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of bases for suppositories].
    Mesikha MS; Iakubov MK; Salo DP
    Farm Zh; 1976; 31(5):71-3. PubMed ID: 1037442
    [No Abstract]   [Full Text] [Related]  

  • 28. [On various special physical properties and reciprocal action of suppositories prepared with witepsol-mass].
    Kata M
    Pharmazie; 1968 Jul; 23(7):368-73. PubMed ID: 5700482
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of the course of melting and solidification of suppository bases].
    Ferratini M; Rigamonti S
    Boll Chim Farm; 1973 Feb; 112(2):116-33. PubMed ID: 4719967
    [No Abstract]   [Full Text] [Related]  

  • 30. [Technology for the production of suppositories containing large amounts of powder and dry extracts].
    Regdon G; Regdon G; Eperjessy I
    Acta Pharm Hung; 1979 Mar; 49(2):88-96. PubMed ID: 443057
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of the properties of polyethylene oxides different degrees of polymerization for the purpose of their use as bases for suppositories].
    Sharova NS; Zaslavskaià RG; Dashevskaià BI; Gluzman MKh
    Farmatsiia; 1971; 20(3):15-8. PubMed ID: 5567849
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of confectionery fat from cotten-seed oil in pharmacy].
    Azhgikhin IS; Sel'verstova LIa; Vittenberg FI
    Farmatsiia; 1967; 16(3):23-8. PubMed ID: 5632983
    [No Abstract]   [Full Text] [Related]  

  • 33. [Technology and quality control of glycerin suppositories].
    Nikolaeva EA; Afner IM; Elizavetina GA; Egerskaia VN; Ignatova AM
    Farmatsiia; 1976; 25(6):46-9. PubMed ID: 1001508
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inclusion of agueous solutions in the suppository mass. Index of emulsionability].
    Ceschel GC; Fontani F; Patane A
    Boll Chim Farm; 1971 Jul; 110(7):400-7. PubMed ID: 5121052
    [No Abstract]   [Full Text] [Related]  

  • 35. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases].
    Pawelczyk E; Zajac M
    Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of a fatty acid ester (Precirol) in drug technology].
    Stampf G; Karoliny V
    Acta Pharm Hung; 1974 Nov; 44(6):283-8. PubMed ID: 4428975
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rectal drug forms].
    Azhgikhin IS
    Farmatsiia; 1968; 17(3):82-7. PubMed ID: 4930405
    [No Abstract]   [Full Text] [Related]  

  • 38. Content uniformity in rectal suppositories.
    Setnikar I; Fontani F
    J Pharm Sci; 1970 Sep; 59(9):1319-24. PubMed ID: 4394257
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the effectiveness of a new type of laxative suppositories].
    Tentsova AI; Azhgikhin IS; Filimonov VG; Sollogub LV; Semchenkova LS
    Farmatsiia; 1971; 20(3):9-15. PubMed ID: 5567868
    [No Abstract]   [Full Text] [Related]  

  • 40. [Method for the determination of the fluidification point of suppositories].
    Magonio E; Ruggieri R; Grano B
    Boll Chim Farm; 1975 Jun; 114(6):343-50. PubMed ID: 1182057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.